Zydus Lifesciences shareholders and shareholding pattern
NSE: ZYDUSLIFEBSE: 532321Pharmaceuticals & BiotechnologyMid Cap
Formerly Cadila Healthcare
Last close ₹1,129.40down ₹5.60 (0.49%)BSE ₹1,127.85
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,135.00.
52-week range of traded prices to 23 Oct 2026
₹835.50Low, 2 Apr 2026₹1,232.10High, 29 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,12,658 Cr114th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 25.0
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹535 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 22.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 4.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.09%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 17.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹535 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 19.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 15.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 15,03,62852.1% delivered
Who owns Zydus Lifesciences, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters75.01%
- Foreign institutions7.05%
- Indian institutions11.28%
- GovernmentsNone
- Individuals and others6.66%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Governments
- Individuals and others
| Per cent | Dec 2016Filed 18 Jan | Mar 2017Filed 10 Apr | Jun 2017Filed 12 Jul | Sep 2017Filed 11 Oct | Dec 2017Filed 12 Jan | Mar 2018Filed 6 Apr | Jun 2018Filed 9 Jul | Sep 2018Filed 10 Oct | Dec 2018Filed 14 Jan | Mar 2019Filed 12 Apr | Jun 2019Filed 6 Jul | Sep 2019Filed 8 Oct | Dec 2019Filed 30 Jan | Mar 2020Filed 20 Apr | Jun 2020Filed 10 Jul | Sep 2020Filed 8 Oct | Dec 2020Filed 20 Jan | Mar 2021Filed 8 Apr | Jun 2021Filed 7 Jul | Sep 2021Filed 6 Oct | Dec 2021Filed 6 Jan | Mar 2022Filed 7 Apr | Jun 2022Filed 7 Jul | Sep 2022Filed 6 Oct | Dec 2022Filed 9 Jan | Mar 2023Filed 8 Apr | Jun 2023Filed 11 Jul | Sep 2023Filed 10 Oct | Dec 2023Filed 8 Jan | Mar 2024Filed 9 Apr | Jun 2024Filed 11 Jul | Sep 2024Filed 9 Oct | Dec 2024Filed 20 Jan | Mar 2025Filed 12 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 14 Oct | Dec 2025Filed 7 Jan | Mar 2026Filed 9 Apr | Jun 2026Filed 11 Jul | Sep 2026Filed 7 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.99% | 74.99% | 74.99% | 75.00% | 75.00% | 75.01% | 75.01% | |
| Indian promoters | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.79% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.88% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.98% | 74.99% | 74.99% | 74.99% | 75.00% | 75.00% | 75.01% | 75.01% |
| Foreign promoters | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | – | – | – | – | Under 0.01% | Under 0.01% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 25.21% | 25.21% | 25.21% | 25.21% | 25.21% | 25.21% | 25.21% | 25.21% | 25.21% | 25.21% | 25.21% | 25.12% | 25.12% | 25.12% | 25.12% | 25.12% | 25.12% | 25.12% | 25.12% | 25.12% | 25.12% | 25.12% | 25.12% | 25.02% | 25.02% | 25.02% | 25.02% | 25.02% | 25.02% | 25.02% | 25.02% | 25.02% | 25.02% | 25.01% | 25.01% | 25.01% | 25.00% | 25.00% | 24.99% | 24.99% |
| Shares in issue | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,27,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,02,37,42,600 | 1,01,22,04,139 | 1,01,22,04,139 | 1,01,22,04,139 | 1,01,22,04,139 | 1,01,22,04,139 | 1,01,22,04,139 | 1,00,62,33,990 | 1,00,62,33,990 | 1,00,62,33,990 | 1,00,62,33,990 | 1,00,62,33,990 | 1,00,62,33,990 | 1,00,62,33,990 | 1,00,62,33,990 | 1,00,62,33,990 | 99,75,03,832 | 99,75,03,832 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Zydus Lifesciences promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Zydus Family Trust (Pankaj R. Patel, Pritiben P. Patel and Sharvil P. Patel-Trustees), 74.98%. The filing names 20 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Zydus Family Trust (Pankaj R. Patel, Pritiben P. Patel and Sharvil P. Patel-Trustees)Indian companies, trusts and others | 74.98% | 74,79,63,801 |
| Arati Rajiv MehtaIndividuals and Hindu undivided families | 0.01% | 75,447 |
| Sharvil Pankajbhai PatelIndividuals and Hindu undivided families | 0.00% | 14,651 |
| Ritaben Yatinbhai DesaiIndividuals and Hindu undivided families | 0.00% | 24,665 |
| Pritiben Pankajbhai PatelIndividuals and Hindu undivided families | 0.00% | 14,651 |
| Prashant Babubhai PatelNon-resident and foreign individuals | 0.00% | 32,577 |
| Samar Babubhai PatelNon-resident and foreign individuals | 0.00% | 10,000 |
| Pankaj Ramanbhai Patel HUF (Pankaj Ramanbhai Patel-Karta)Individuals and Hindu undivided families | 0.00% | 29,302 |
| Pankaj Ramanbhai PatelIndividuals and Hindu undivided families | 0.00% | 43,969 |
| Pripan Investment Private LimitedIndian companies, trusts and others | 0.00% | 17,581 |
| Taraben Patel Family Will Trust (Mr.Pankaj R Patel and Dr. Sharvil P Patel-Trustees)Indian companies, trusts and others | 0.00% | 14,651 |
| Ayushi Rajiv Mehta jointly with Arati Rajiv MehtaIndividuals and Hindu undivided families | 0.00% | 17,727 |
No promoter shares are reported as pledged.
Largest public holders of Zydus Lifesciences, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Zydus Lifesciences
| Holder | Dec 2016Filed 18 Jan | Mar 2017Filed 10 Apr | Jun 2017Filed 12 Jul | Sep 2017Filed 11 Oct | Dec 2017Filed 12 Jan | Mar 2018Filed 6 Apr | Jun 2018Filed 9 Jul | Sep 2018Filed 10 Oct | Dec 2018Filed 14 Jan | Mar 2019Filed 12 Apr | Jun 2019Filed 6 Jul | Sep 2019Filed 8 Oct | Dec 2019Filed 30 Jan | Mar 2020Filed 20 Apr | Jun 2020Filed 10 Jul | Sep 2020Filed 8 Oct | Dec 2020Filed 20 Jan | Mar 2021Filed 8 Apr | Jun 2021Filed 7 Jul | Sep 2021Filed 6 Oct | Dec 2021Filed 6 Jan | Mar 2022Filed 7 Apr | Jun 2022Filed 7 Jul | Sep 2022Filed 6 Oct | Dec 2022Filed 9 Jan | Mar 2023Filed 8 Apr | Jun 2023Filed 11 Jul | Sep 2023Filed 10 Oct | Dec 2023Filed 8 Jan | Mar 2024Filed 9 Apr | Jun 2024Filed 11 Jul | Sep 2024Filed 9 Oct | Dec 2024Filed 20 Jan | Mar 2025Filed 12 Apr | Jun 2025Filed 18 Jul | Sep 2025Filed 14 Oct | Dec 2025Filed 7 Jan | Mar 2026Filed 9 Apr | Jun 2026Filed 11 Jul | Sep 2026Filed 7 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Life Insurance Corporation of IndiaInsurance companies | 2.77% | 2.77% | 2.77% | – | 2.92% | 2.81% | 2.81% | 2.81% | 2.81% | 2.81% | 2.81% | 3.52% | 3.69% | 3.72% | 3.45% | 3.17% | 2.36% | 3.30% | 3.63% | 5.68% | 6.13% | 6.13% | 6.34% | – | – | – | – | – | – | – | – | – | – | 3.85% | 4.62% | 5.32% | 5.55% | 5.56% | 5.41% | 3.77% |
| Llife Insurance Corporation of IndiaInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.35% | 6.23% | 6.23% | 5.98% | 5.30% | 4.57% | 4.43% | 3.89% | 3.09% | 3.53% | – | – | – | – | – | – | – |
| Government Pension Fund GlobalInstitutions Foreign Portfolio Investor | 1.06% | 1.06% | 1.06% | 1.06% | – | – | – | 1.06% | 1.06% | 1.13% | 1.13% | 1.13% | 1.13% | 1.13% | 1.12% | – | 1.18% | 1.18% | 1.15% | 1.17% | 1.19% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Government Pension Fund BlobalInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | 1.06% | – | – | – | – | – | – | – | – | 1.11% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| GOVERNMENT PENSION GLOBAL SCHEMEInstitutions Foreign Portfolio Investor | – | – | – | – | – | 1.06% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Government Pension Global FundInstitutions Foreign Portfolio Investor | – | – | – | – | 1.06% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Franklin Templeton Investment FundInstitutions Foreign Portfolio Investor | – | – | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| FRANKLIN TEMPLELTON INVESTMENT FUNDSInstitutions Foreign Portfolio Investor | – | 1.27% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Franklin Templetion Investment FundsInstitutions Foreign Portfolio Investor | 1.30% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.